Evidence map›Paper›PMID 25848530›Full record

ArticleJournal of biomedical semantics2015

Development and validation of a classification approach for extracting severity automatically from electronic health records.

Mary Regina Boland, Nicholas P Tatonetti, George Hripcsak

Abstract read
In one paragraph

Article in Journal of biomedical semantics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Automatic health record review to help prioritize gravely ill Social Security disability applicants.Journal of the American Medical Informatics Association : JAMIA · 2017
    Article
  4. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability.Journal of the American Medical Informatics Association : JAMIA · 2016
    Article
  5. The digital revolution in phenotyping.Briefings in bioinformatics · 2016
    Article
  6. Article
  7. Clinical Genomics: Challenges and Opportunities.Critical reviews in eukaryotic gene expression · 2016
    Review
  8. Special issue on bio-ontologies and phenotypes.Journal of biomedical semantics · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mary Regina BolandDepartment of Biomedical Informatics, Columbia University, New York, NY USA ; Observational Health Data Sciences and Informatics (OHDSI), Columbia University, 622 West 168th Street, PH-20, New York, NY USA.
Nicholas P TatonettiDepartment of Biomedical Informatics, Columbia University, New York, NY USA ; Observational Health Data Sciences and Informatics (OHDSI), Columbia University, 622 West 168th Street, PH-20, New York, NY USA ; Department of Systems Biology, Columbia University, New York, NY USA ; Department of Medicine, Columbia University, New York, NY USA.
George HripcsakDepartment of Biomedical Informatics, Columbia University, New York, NY USA ; Observational Health Data Sciences and Informatics (OHDSI), Columbia University, 622 West 168th Street, PH-20, New York, NY USA.

Funding

DISCOVERING AND APPLYING KNOWLEDGE IN CLINICAL DATABASESR01LM006910 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HRIPCSAK, GEORGE M · 2000 to 2023
$10.6M
Drug Effect Discovery Through Data Mining and Integrative Chemical BiologyR01GM107145 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TATONETTI, NICHOLAS P · 2014 to 2018
$2.5M
NIGMS NIH HHS R01 GM107145NLM NIH HHS R01 LM006910
6 · The paper itself

Abstract

backgroundElectronic Health Records (EHRs) contain a wealth of information useful for studying clinical phenotype-genotype relationships. Severity is important for distinguishing among phenotypes; however other severity indices classify patient-level severity (e.g., mild vs. acute dermatitis) rather than phenotype-level severity (e.g., acne vs. myocardial infarction). Phenotype-level severity is independent of the individual patient's state and is relative to other phenotypes. Further, phenotype-level severity does not change based on the individual patient. For example, acne is mild at the phenotype-level and relative to other phenotypes. Therefore, a given patient may have a severe form of acne (this is the patient-level severity), but this does not effect its overall designation as a mild phenotype at the phenotype-level.

methodsWe present a method for classifying severity at the phenotype-level that uses the Systemized Nomenclature of Medicine - Clinical Terms. Our method is called the Classification Approach for Extracting Severity Automatically from Electronic Health Records (CAESAR). CAESAR combines multiple severity measures - number of comorbidities, medications, procedures, cost, treatment time, and a proportional index term. CAESAR employs a random forest algorithm and these severity measures to discriminate between severe and mild phenotypes.

resultsUsing a random forest algorithm and these severity measures as input, CAESAR differentiates between severe and mild phenotypes (sensitivity = 91.67, specificity = 77.78) when compared to a manually evaluated reference standard (k = 0.716).

conclusionsCAESAR enables researchers to measure phenotype severity from EHRs to identify phenotypes that are important for comparative effectiveness research.

Indexed as

Data miningElectronic Health RecordsHealth status indicatorsOutcome assessment (Health Care)Phenotype

Identifiers

PMID25848530
PMCPMC4386082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.